miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease

Parkinson’s Disease is the second most common neurodegenerative disorder, affecting 1–2% of the elderly population. Its diagnosis is still based on the identification of motor symptoms when a considerable number of dopaminergic neurons are already lost. The development of translatable biomarkers for...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos, Marcia Cristina T., Barreto-Sanz, Miguel Arturo, Correia, Bruna Renata S., Bell, Rosie, Widnall, Catherine, Perez, Luis Tosar, Berteau, Caroline, Schulte, Claudia, Scheller, Dieter, Berg, Daniela, Maetzler, Walter, Galante, Pedro A.F., Nogueira da Costa, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915128/
https://www.ncbi.nlm.nih.gov/pubmed/29707120
http://dx.doi.org/10.18632/oncotarget.24736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915128/
https://www.ncbi.nlm.nih.gov/pubmed/29707120
http://dx.doi.org/10.18632/oncotarget.24736

Ejemplares similares